Cohort 
2016

Ioannis Tarnanas, PhD, MSc

Neuroscientist

We must engage, inform, and educate the next generation of scientists—and the public—about the power of big data and its potential to advance medical progress

Current Work

Ioannis is a neuroscientist focused on using new technologies to understand the aging process and to establish prevention methods that decrease the risk of developing dementia or delay the onset of the disease. He is the Chief Scientific Officer of Altoida, Inc.

Vision

Ioannis believes we must engage, inform, and educate the next generation of scientists—and the public—about the power of big data and its potential to advance medical progress

Strategy

Ioannis is developing computational biomarkers of Alzheimer’s disease and developing a responsible strategy to implement this technology and utilize machine intelligence for disease prevention.

Impact

Ioannis has developed models and screens of dementia using computerized tests of complex, real-life activities, such as a novel assessment of spatial navigation and movement trajectory. With this technology, he recently created an accurate predictive tool based on cognitive and non-cognitive biomarkers of early-onset dementia.

Motivation

Greece has had a national dementia plan since 2002 but is not modernized or on par with other developed countries in central Europe or the USA. There is a disconnect between services and offers on paper and the hard reality for people with dementia and their carers.

Education & Experience

Global Brain Health Institute (GBHI)
2016
Atlantic Fellow for Equity in Brain Health
Aristotle University of Thessaloniki in Greece
Neuroscience
PhD
MSc